Literature DB >> 13446795

The value of chloroquine in rheumatoid disease: a four-year study of continuous therapy.

A W BAGNALL.   

Abstract

Entities:  

Keywords:  CHLOROQUINE/therapeutic use; RHEUMATISM/therapy

Mesh:

Substances:

Year:  1957        PMID: 13446795      PMCID: PMC1824026     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


× No keyword cloud information.
  4 in total

1.  Chloroquine therapy in rheumatoid arthritis.

Authors:  R E RINEHART
Journal:  Northwest Med       Date:  1955-07

2.  The management of Marie-Strumpell spondylitis with special reference to long-term cortisone therapy.

Authors:  A W BAGNALL; J A TRAYNOR; H W MCINTOSH
Journal:  Can Med Assoc J       Date:  1953-06       Impact factor: 8.262

3.  Treatment of lupus erythematosus with mepacrine.

Authors:  F PAGE
Journal:  Lancet       Date:  1951-10-27       Impact factor: 79.321

4.  Mepacrine and rheumatoid arthritis.

Authors:  A FREEDMAN; F BACH
Journal:  Lancet       Date:  1952-08-16       Impact factor: 79.321

  4 in total
  15 in total

1.  [STUDIES ON THE INHIBITORY EFFECT OF CHLOROQUIN (RESOCHIN) ON CELL PROLIFERATION IN VITRO].

Authors:  R LIPP
Journal:  Arch Klin Exp Dermatol       Date:  1964-02-06

2.  BONE MARROW DEPRESSION AFTER DRUG THERAPY IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS.

Authors:  F C MCDUFFIE
Journal:  Ann Rheum Dis       Date:  1965-05       Impact factor: 19.103

3.  Chloroquine in rheumatoid arthritis; a double blindfold trial of treatment for one year.

Authors:  A FREEDMAN; V L STEINBERG
Journal:  Ann Rheum Dis       Date:  1960-09       Impact factor: 19.103

4.  Chloroquine diphosphate in rheumatoid arthritis. A controlled trial.

Authors:  A J POPERT; K A MEIJERS; J SHARP; F BIER
Journal:  Ann Rheum Dis       Date:  1961-03       Impact factor: 19.103

5.  Disturbances of pigmentation with chloroquine.

Authors:  J L DALL; J A KEANE
Journal:  Br Med J       Date:  1959-05-30

6.  Antimalarial compounds in rheumatoid disease.

Authors:  A W BAGNALL
Journal:  Can Med Assoc J       Date:  1960-06-04       Impact factor: 8.262

7.  Controversies in the treatment of rheumatoid arthritis.

Authors:  O Savage
Journal:  Proc R Soc Med       Date:  1969-02

8.  Study of chloroquine toxicity and a drug-induced cerebrospinal lipodystrophy in swine.

Authors:  C A Gleiser; W W Bay; T W Dukes; R S Brown; W K Read; K R Pierce
Journal:  Am J Pathol       Date:  1968-07       Impact factor: 4.307

9.  Differential diagnosis of high serum creatine kinase levels in systemic lupus erythematosus.

Authors:  Jutta G Richter; Arnd Becker; Benedikt Ostendorf; Christof Specker; G Stoll; E Neuen-Jacob; Matthias Schneider
Journal:  Rheumatol Int       Date:  2003-05-09       Impact factor: 2.631

10.  Chloroquine in long-term treatment of rheumatoid arthritis.

Authors:  A Bjelle; A Björnham; A Larsen; T Mjörndal
Journal:  Clin Rheumatol       Date:  1983-12       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.